18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma

Published:2017-11-08 Issue:2 Volume:22 Page:279-287
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Ariake Kyohei,Motoi Fuyuhiko,Shimomura Hideo,Mizuma Masamichi,Maeda Shimpei,Terao Chiaki,Tatewaki Yasuko,Ohtsuka Hideo,Fukase Koji,Masuda Kunihiro,Hayashi Hiroki,Takadate Tatsuyuki,Naitoh Takeshi,Taki Yasuyuki,Unno Michiaki

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/article/10.1007/s11605-017-3627-3/fulltext.html

Reference26 articles.

1. Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17–1.

2. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW; European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200–1210.

3. Smeenk HG, van Eijck CH, Hop WC, Erdmann J, Tran KC, Debois M, van Cutsem E, van Dekken H, Klinkenbijl JH, Jeekel J. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg 2007;246:734–740.

4. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 2006;10:511–518.

5. Ariake K, Motoi F, Ohtsuka H, Fukase K, Masuda K, Mizuma M, Hayashi H, Nakagawa K, Morikawa T, Maeda S, Takadate T, Naitoh T, Egawa S, Unno M. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention. Surg Today 2017. doi: https://doi.org/10.1007/s00595-017-1531-9 .

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Single-Center, Retrospective Study;Annals of Surgical Oncology;2023-10-18

2. “Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022;Pancreatology;2023-09

3. Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy;Journal of Gastrointestinal Surgery;2023-01-18

4. 18F-FDG PET/CT in peritoneal tumors: a pictorial review;Clinical and Translational Imaging;2023-01-07

5. High SUVmax on routine pre-operative FDG-PET predicts early recurrence in pancreatic and peri-ampullary cancer;HPB;2022-08